Skip to main content

Arbutus Biopharma Cp(ABUS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume
Day Low2.45
Day High2.56
Open:2.50
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest News

Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript
Motley Fool - Thu Aug 4, 6:30PM CDT
Motley Fool
Thu Aug 4, 6:30PM CDT
ABUS earnings call for the period ending June 30, 2022.
Arbutus Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Globe Newswire - Thu Aug 4, 6:30AM CDT
Globe Newswire
Thu Aug 4, 6:30AM CDT
Key milestones across our chronic hepatitis B virus (cHBV) and pan-coronavirus programs remain on track Financially strong with a projected cash runway...
Arbutus to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Globe Newswire - Thu Jul 21, 6:30AM CDT
Globe Newswire
Thu Jul 21, 6:30AM CDT
WARMINSTER, Pa., July 21, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...

Latest Articles

Tekmira abandons Ebola drug development, changing focus to hepatitis B cure